Exchange: NASDAQ·Updated 09:05 AM EDT
VIR logo

VIR Vir Biotechnology Inc

$10.55
$0.05
(0.47%)
Pre-Market
Prev Close $10.60
EarningsNov 4
Mkt Cap$1.79B
Vol366.00

About VIR

Vir Biotechnology, Inc. operates as a clinical-stage immunology company that focuses on combining immunologic insights with cutting-edge technologies to treat and prevent serious infectious diseases. The firm's technology platforms include antibody, T cell, innate immunity and siRNA, which are designed to stimulate and enhance the immune system by exploiting critical observations of natural immune processes. The company was founded by Robert Taylor Nelsen, Klaus Frueh, Jay Parrish, Lawrence Corey, and Louis Picker in April 7, 2016 and is headquartered in San Francisco, CA.
29

Bearish Sentiment

How do you feel about VIR?

Advertisement|Remove ads.